"Chorionic Gonadotropin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN).
| Descriptor ID |
D006063
|
| MeSH Number(s) |
D06.472.699.322.326 D06.472.699.649.367 D12.644.548.726.367 D12.776.780.400
|
| Concept/Terms |
Chorionic Gonadotropin, Human- Chorionic Gonadotropin, Human
- Gonadotropin, Human Chorionic
- Human Chorionic Gonadotropin
- HCG (Human Chorionic Gonadotropin)
|
Below are MeSH descriptors whose meaning is more general than "Chorionic Gonadotropin".
Below are MeSH descriptors whose meaning is more specific than "Chorionic Gonadotropin".
This graph shows the total number of publications written about "Chorionic Gonadotropin" by people in this website by year, and whether "Chorionic Gonadotropin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1996 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chorionic Gonadotropin" by people in Profiles.
-
Mattiello CJ, Stickle DF. Characterization by image analysis of the dose vs response curve for a qualitative serum hCG lateral flow immunoassay. Clin Chim Acta. 2023 Jan 01; 538:175-180.
-
Pirtea P, de Ziegler D, Marin D, Sun L, Tao X, Ayoubi JM, Franasiak J, Scott RT. Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology. Fertil Steril. 2022 09; 118(3):494-503.
-
Vinekar K, Achilles SL, Chen BA. Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate. Contraception. 2021 10; 104(4):444-446.
-
Hong KH, Forman EJ, Werner MD, Upham KM, Gumeny CL, Winslow AD, Kim TJ, Scott RT. Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2014 Dec; 102(6):1591-5.e2.
-
Fan J, Traore K, Li W, Amri H, Huang H, Wu C, Chen H, Zirkin B, Papadopoulos V. Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells. Endocrinology. 2010 Jul; 151(7):3348-62.
-
Kocdor H, Kocdor MA, Russo J, Snider KE, Vanegas JE, Russo IH, Fernandez SV. Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. Cell Biol Int. 2009 Nov; 33(11):1135-43.
-
Moragianni VA, Cohen JD, Smith SE, Schinfeld JS, Somkuti SG, Lee A, Barmat LI. Effect of macroscopic or microscopic blood and mucus on the success rates of embryo transfers. Fertil Steril. 2010 Feb; 93(2):570-3.
-
Brahma PK, Kallen CB. Ovarian hyperstimulation after a short course of an oral contraceptive in a patient with premature ovarian failure. Fertil Steril. 2008 Nov; 90(5):2004.e15-7.
-
Duffield AS, Jarrar P, Shum C, Ahuja N, Yeo CJ, Sokoll LJ. Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two cases. Clin Chim Acta. 2008 Sep; 395(1-2):166-9.
-
Meldrum DR, Scott RT, Levy MJ, Alper MM, Noyes N. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril. 2009 May; 91(5):1963-5.